AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 63 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 7.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $42,000 | -19.2% | 10,500 | +5.0% | 0.00% | -33.3% |
| Q1 2021 | $52,000 | -89.6% | 10,000 | -90.3% | 0.00% | -93.8% |
| Q3 2020 | $501,000 | -24.7% | 103,240 | -24.6% | 0.05% | -23.8% |
| Q2 2020 | $665,000 | +250.0% | 136,923 | +57.8% | 0.06% | +173.9% |
| Q1 2020 | $190,000 | -47.7% | 86,766 | +39.0% | 0.02% | -28.1% |
| Q4 2019 | $363,000 | +16.0% | 62,434 | -36.6% | 0.03% | +3.2% |
| Q3 2019 | $313,000 | +5.4% | 98,489 | +39.2% | 0.03% | +3.3% |
| Q2 2019 | $297,000 | – | 70,733 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
| WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
| Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |